Concepedia

Results of the Prospective Randomized UroFollow Trial Comparing Marker-guided Versus Cystoscopy-based Surveillance in Patients with Low/Intermediate-risk Bladder Cancer

Bernd J. Schmitz-Dräger, E. Bismarck, Florian Roghmann, Nicolas von Landenberg, Joachim Noldus, Daniela Jahn, Karoline Kernig, Oliver W. Hakenberg, Peter J. Goebell, Jörg Hennenlotter,

European Urology Oncology · 2025 · 11 citations · 14 references

DOI

Concepts

References

14

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration

Jérémie F. Cohen, Daniël A. Korevaar, Douglas G. Altman et al. · BMJ Open · 2016 · 2.5K citations · Full text

, , +6

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

Richard Sylvester, Óscar Rodríguez, Virginia Hernández et al. · European Urology · 2021 · 463 citations

, , +10

Economic Burden of Bladder Cancer Across the European Union

José Leal, Ramón Luengo-Fernández, Richard Sullivan et al. · European Urology · 2015 · 333 citations · Full text

, , +17

Cystoscopy Revisited as the Gold Standard for Detecting Bladder Cancer Recurrence: Diagnostic Review Bias in the Randomized, Prospective CEFUB Trial

Madelon N.M. van der Aa, Ewout W. Steyerberg, Chris H. Bangma et al. · The Journal of Urology · 2009 · 126 citations

, , +11

Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer

Faysal A. Yafi, Fadi Brimo, Manon Auger et al. · Urologic Oncology Seminars and Original Investigations · 2013 · 107 citations

, , +16